Biopharmaceutical Market - Forecast(2019 - 2024)

Report Code: HCR 0054 Report Format: PDF + Excel Database

Biopharmaceutical Market overview :

According to the Centro De Innovacao e Ensaios Pre-Clinicos (CIEnP), the global biopharmaceutical market is observing a growth with a total number of 155 new biopharmaceutical products approved in the United States and European Union between the survey period of January 2014 and July 2018.[i] This largely attributes to the growing demand for biopharmaceutical medicines across the globe due to which the biopharmaceutical market had an impressive market size of $238,200 million as of 2018. Furthermore, the demand for biopharmaceutical products will increase with a staggering compound annual growth rate (CAGR) of 12.8% during the forecast period of 2019 to 2025.

There is an augmented healthcare expenditure in North America owing to its developed economy that has led to a perceptibly excellent healthcare infrastructure. The most part of the demand for innovation in the biopharmaceutical market is sufficed by the region, and it’s quite evident when the pharmaceutical industry in the United States alone employs 854,000 million people with expenditure on services and supplies translating to $659 billion. Furthermore, the International Federation of Pharmaceutical Manufacturing Association (IFPMA) documented in their 2017 report that the U.S. biopharmaceutical industry supported 5.21 jobs outside the pharmaceutical sector.[ii] Considering that a major part of biopharmaceutical drugs get approval in the region, North America held the greatest biopharmaceutical market share of 33% in 2018.

Biopharmaceutical Market Outlook :

A biopharmaceutical is also known as biologic which is semi synthesized from biological sources or produced from microbial cells such as recombinant E. coli and includes allergenics, somatic cells, and nucleic acids. Biopharmaceutical products have now become an integral part of the pharmaceutical industry because the biopharmaceutical products have a structure similar to that of a human compound and are found to have greater efficacy in curing the diseases.

The major application segment of the biopharmaceutical market is found to be in hospitals. Biopharmaceutical medicines are yet to gain prominence in the over-the-counter sector of medicine distribution. This is predominantly because it is still necessary to consume biopharmaceutical drugs on a physician’s prescription. Furthermore, many of the biopharmaceutical medicines are personalized and cure specific diseases that are treated in hospitals. So, they are widely used in hospitals wherein patients are provided the medicines on a certified HCP’s prescription. The biopharmaceutical market will observe the application of products in the hospitals to grow with a superlative CAGR of 11% through to 2025. 

Biopharmaceutical Market Growth Drivers :

·         The Rise in Lethal Diseases and the Efficacy of Biopharmaceutical Drugs –

According to the International Agency for Research on Cancer (IARC), there were 18.1 million new cases of cancer and 9.6 million deaths in 2018.[iii] Furthermore, the United Nations Programme on HIV and AIDS (UNAIDS) had documented that 36.9 million people were living with HIV in 2017.[iv] These disquieting figures are giving rise to a dire need for ameliorating the situation by innovating new and effective drugs that can cure these fatal diseases and subsequently reduce the number of deaths. Apparently, the biopharmaceutical medicines are found to be effective in curing these chronic diseases rather than just treating the symptoms of the same. This is leading to an enormous number of opportunities in the biopharmaceutical market.

·         The Genomics Industry Aiding to Biopharmaceutical –

The genomics industry is making strides in the pharmaceutical sector and more so when there is a consistent demand for personalized vaccines for various diseases. The innovations in genomics are leading to drug discovery which is aiding to the developments in the biopharmaceutical market.  According to a business intelligence report by IndustryARC, the genomics market size was gauged to be $16 billion to $16.5 billion as of 2018, and the market demand will be observing a CAGR of a healthy 9.2% to 10.2% through to 2025. This growth during the forecast period will have a positive influence on the biopharmaceutical industry, and the market is poised to observe more biopharmaceutical drugs.

·         The Significant Rise in the Geriatric Population –

The global population of aged people is increasing, and it is projected to catapult at a massive rate in the future. Evidently, aged people suffer from a gamut of geriatric conditions that are now also treated using biopharmaceutical medicines which is chiefly supporting the biopharmaceutical market.

 

Biopharmaceutical Market trends :

·    In April 2018, Takeda Pharmaceutical had bid to acquire Shire for a sum of $63 billion. The acquisition was mainly targeted to position the company in the biopharmaceutical market.

·    In January 2018, France-based Sanofi acquired Massachusetts-based Bioverativ for $11.6 billion.

·    In January 2018, Seattle Genetics acquired Cascadian Therapeutics for a sum of $614 million.

Biopharmaceutical Market Challenges :

The major challenge faced by the manufacturers in the biopharmaceutical market is the tangible upsurge in the manufacturing budget due to the rise in the cost of bioprocessing. This leads to an upsurge in the cost of the final product that dwarfs the biopharmaceutical market size. On the other hand, there is a growing awareness about the biopharmaceutical products which is creating market Revenue Avenue for the vendors. Furthermore, some of the biopharmaceutical medicines are found to be physically and chemically unstable and undergo degradation in the form of isomerization, hydrolysis or oxidation. However, there is a tangible surge in the investment in R&D to formulate biopharmaceutical drugs that are stable.     

Biopharmaceutical Market Key Players Perspective :

The key players striving to capitalize on the project demand for the biopharmaceutical products are Roche Holding AG, Abbott Laboratories, Bristol-Myers Squibb, Novartis International AG, Genentech, Inc., Merck KGaA, Merck Serono, Amgen Inc., Eli Lilly and Company, and Biogen Inc.

Biopharmaceutical Market Research Scope :

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the biopharmaceutical market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the specific applications of biopharmaceutical products in oncology and cardiology. Moreover, the report provides insights about their applications in hospitals.

Biopharmaceutical Market Report: Industry Coverage :

The report analyses the product demand of biopharmaceutical by source that can be unicellular or multicellular Systems and its manufacturing by single and multi-use systems.  

The biopharmaceutical market report also analyzes the major geographic regions as well as the major countries in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, the Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

Middle East and Africa: Israel, South Africa, Saudi Arabia

Key Questions Addressed in the biopharmaceutical Market Report :

Is the market demand for biopharmaceutical growing? How long will it continue to grow and at what rate?

Which type of home security system presents the major growth opportunities?

Is there a possibility for change in the market structure over time?

Are additional developments needed for the existing product or services offerings or do the existing products meet the customer demands?

Do the key vendors look for partnerships to expand their businesses with respect to geography or product?

What are the short-term, long-term, and medium-term growth drivers for the market?

What are the short-term, medium-term, and long-term challenges for the market?

What are the short-term, medium-term, and long-term opportunities for the market

Who are the top players/companies of the market?

What are the recent innovations in the market?

How many patents have been filed by the leading players?

What are the types of patents filed by the leading players?

What is our Vision 2030 for the biopharmaceutical market?

A Few Focus Points Of This Research Are Given Below :

Give a deep-dive analysis of the key operational strategies with focus on the corporate structure, R&D strategies, localization strategies, production capabilities, and sales performance of various companies

Provide an overview of the product portfolio, including product planning, development, and positioning

Discuss the role of technology companies in partnerships

Explore the regional sales activities

Analyze the market size and giving the forecast for current and future global biopharmaceutical market during the forecast 2018–2023

Analyze the competitive factors, competitors’ market shares, product capabilities, and supply chain structures


References - 

[i] http://cienp.org.br/wp-content/uploads/2018/12/Biopharmaceutical-benchmarks-2018.pdf

[ii] https://www.ifpma.org/wp-content/uploads/2017/02/IFPMA-Facts-And-Figures-2017.pdf

[iii] https://www.who.int/cancer/PRGlobocanFinal.pdf

[iv] http://www.unaids.org/en/resources/fact-sheet

1. Biopharmaceutical Market - Overview
1.1. Definitions and Scope
2. Biopharmaceutical Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Biopharmaceutical Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Biopharmaceutical Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Biopharmaceutical Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Biopharmaceutical Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Biopharmaceutical Market - Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Biopharmaceutical Market – By Source (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Unicellular System
8.3.1.1. Bacteria
8.3.1.2. Yeast
8.3.1.3. Insect
8.3.2. Multicellular System
8.3.2.1. Transgenic Plant
8.3.2.2. Transgenic Animal
9. Biopharmaceutical Market – By Products (Market Size -$Million / $Billion)
9.1. Vaccines
9.2. Hormones
9.3. Enzymes
9.4. Blood
9.5. Blood Components
9.6. Monoclonal Antibodies
9.7. Growth Factors
9.8. Gene Therapies
9.9. Thrombolytics and Anticoagulants
9.10. Recombinant Therapeutic Protein
10. Biopharmaceutical Market – By Manufacturing Process (Market Size -$Million / $Billion)
10.1. Single-Use System
10.2. Multi- Use System
11. Biopharmaceutical Market – By Application (Market Size -$Million / $Billion)
11.1. Rheumatology
11.2. Oncology
11.3. Cardiology
11.4. Dermatology
11.5. Gastroenterology
11.6. Neurology
11.7. Others
12. Biopharmaceutical – By End Use Industry(Market Size -$Million / $Billion)
12.1. Segment type Size and Market Share Analysis 
12.2. Application Revenue and Trends by type of Application
12.3. Application Segment Analysis by Type
12.3.1. Biopharmaceutical Companies
12.3.2. Hospitals
12.3.3. Research Institutes
12.3.4. CROs
12.3.5. Diagnostic Labs
13. Biopharmaceutical - By Geography (Market Size -$Million / $Billion)
13.1. Biopharmaceutical Market - North America Segment Research
13.2. North America Market Research (Million / $Billion)
13.2.1. Segment type Size and Market Size Analysis 
13.2.2. Revenue and Trends
13.2.3. Application Revenue and Trends by type of Application
13.2.4. Company Revenue and Product Analysis
13.2.5. North America Product type and Application Market Size
13.2.5.1. U.S.
13.2.5.2. Canada 
13.2.5.3. Mexico 
13.2.5.4. Rest of North America
13.3. Biopharmaceutical - South America Segment Research
13.4. South America Market Research (Market Size -$Million / $Billion)
13.4.1. Segment type Size and Market Size Analysis 
13.4.2. Revenue and Trends
13.4.3. Application Revenue and Trends by type of Application
13.4.4. Company Revenue and Product Analysis
13.4.5. South America Product type and Application Market Size
13.4.5.1. Brazil  
13.4.5.2. Venezuela
13.4.5.3. Argentina
13.4.5.4. Ecuador
13.4.5.5. Peru
13.4.5.6. Colombia 
13.4.5.7. Costa Rica
13.4.5.8. Rest of South America
13.5. Biopharmaceutical - Europe Segment Research
13.6. Europe Market Research (Market Size -$Million / $Billion)
13.6.1. Segment type Size and Market Size Analysis 
13.6.2. Revenue and Trends
13.6.3. Application Revenue and Trends by type of Application
13.6.4. Company Revenue and Product Analysis
13.6.5. Europe Segment Product type and Application Market Size
13.6.5.1. U.K  
13.6.5.2. Germany 
13.6.5.3. Italy 
13.6.5.4. France
13.6.5.5. Netherlands
13.6.5.6. Belgium
13.6.5.7. Spain
13.6.5.8. Denmark
13.6.5.9. Rest of Europe
13.7. Biopharmaceutical – APAC Segment Research
13.8. APAC Market Research (Market Size -$Million / $Billion)
13.8.1. Segment type Size and Market Size Analysis 
13.8.2. Revenue and Trends
13.8.3. Application Revenue and Trends by type of Application
13.8.4. Company Revenue and Product Analysis
13.8.5. APAC Segment – Product type and Application Market Size
13.8.5.1. China 
13.8.5.2. Australia
13.8.5.3. Japan 
13.8.5.4. South Korea
13.8.5.5. India
13.8.5.6. Taiwan
13.8.5.7. Malaysia
14. Biopharmaceutical Market - Entropy
16.1. New product launches
16.2. M&A's, collaborations, JVs and partnerships
15. Biopharmaceutical Market – Industry / Segment Competition landscape Premium
15.1. Market Share Analysis
15.1.1. Market Share by Country- Top companies
15.1.2. Market Share by Region- Top 10 companies
15.1.3. Market Share by type of Application – Top 10 companies
15.1.4. Market Share by type of Product / Product category- Top 10 companies
15.1.5. Market Share at global level- Top 10 companies
15.1.6. Best Practises for companies
16. Biopharmaceutical Market – Key Company List by Country Premium
17. Biopharmaceutical Market Company Analysis
17.1. Market Share, Company Revenue, Products, M&A, Developments
17.2. Roche Holding AG
17.3. Abbott Laboratories
17.4. Bristol-Myers Squibb
17.5. Novartis International AG
17.6. Genentech Inc.
17.7. UCB
17.8. Merck Serono
17.9. Amgen
17.10. Eli Lilly & Co.
17.11. Biogen Idec
17.12. Merck KGaA
17.13. Élan Corporation
17.14. BioMarin Pharmaceutical Inc.
17.15. AbbVie Inc.
17.16. Invion Limited
17.17. AdAlta Pty Ltd.
17.18. Admedus Ltd
17.19. Biota Pharmaceuticals Inc.
17.20. Novozymes
17.21. Baxter International
17.22. APEIRON Biologics AG
17.23. Octapharma AG
17.24. Valneva SE
17.25. Genzyme
17.26. Mallinckrodt Pharmaceuticals
17.27. TM3 Therapeutics
"*Financials would be provided on a best efforts basis for private companies"
18. Biopharmaceutical Market - Appendix
18.1. Abbreviations
18.2. Sources
19. Biopharmaceutical Market - Methodology
19.1. Research Methodology
19.1.1. Company Expert Interviews
19.1.2. Industry Databases
19.1.3. Associations
19.1.4. Company News
19.1.5. Company Annual Reports
19.1.6. Application Trends
19.1.7. New Products and Product database
19.1.8. Company Transcripts
19.1.9. R&D Trends
19.1.10. Key Opinion Leaders Interviews
19.1.11. Supply and Demand Trends
List of Tables:

Table 1: Biopharmaceutical Market Overview 2019-2024
Table 2: Biopharmaceutical Market Leader Analysis 2018-2019 (US$)
Table 3: Biopharmaceutical Market Product Analysis 2018-2019 (US$)
Table 4: Biopharmaceutical Market End User Analysis 2018-2019 (US$)
Table 5: Biopharmaceutical Market Patent Analysis 2013-2018* (US$)
Table 6: Biopharmaceutical Market Financial Analysis 2018-2019 (US$)
Table 7: Biopharmaceutical Market Driver Analysis 2018-2019 (US$)
Table 8: Biopharmaceutical Market Challenges Analysis 2018-2019 (US$)
Table 9: Biopharmaceutical Market Constraint Analysis 2018-2019 (US$)
Table 10: Biopharmaceutical Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Biopharmaceutical Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Biopharmaceutical Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Biopharmaceutical Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Biopharmaceutical Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Biopharmaceutical Market Value Chain Analysis 2018-2019 (US$)
Table 16: Biopharmaceutical Market Pricing Analysis 2019-2024 (US$)
Table 17: Biopharmaceutical Market Opportunities Analysis 2019-2024 (US$)
Table 18: Biopharmaceutical Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Biopharmaceutical Market Supplier Analysis 2018-2019 (US$)
Table 20: Biopharmaceutical Market Distributor Analysis 2018-2019 (US$)
Table 21: Biopharmaceutical Market Trend Analysis 2018-2019 (US$)
Table 22: Biopharmaceutical Market Size 2018 (US$)
Table 23: Biopharmaceutical Market Forecast Analysis 2019-2024 (US$)
Table 24: Biopharmaceutical Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Biopharmaceutical Market, Revenue & Volume, By Source, 2019-2024 ($)
Table 26: Biopharmaceutical Market By Source, Revenue & Volume, By Unicellular System, 2019-2024 ($)
Table 27: Biopharmaceutical Market By Source, Revenue & Volume, By Bacteria, 2019-2024 ($)
Table 28: Biopharmaceutical Market By Source, Revenue & Volume, By Yeast, 2019-2024 ($)
Table 29: Biopharmaceutical Market By Source, Revenue & Volume, By Insect, 2019-2024 ($)
Table 30: Biopharmaceutical Market By Source, Revenue & Volume, By Multicellular System, 2019-2024 ($)
Table 31: Biopharmaceutical Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 32: Biopharmaceutical Market By Product, Revenue & Volume, By Vaccines, 2019-2024 ($)
Table 33: Biopharmaceutical Market By Product, Revenue & Volume, By Hormones, 2019-2024 ($)
Table 34: Biopharmaceutical Market By Product, Revenue & Volume, By Enzymes, 2019-2024 ($)
Table 35: Biopharmaceutical Market By Product, Revenue & Volume, By Blood, 2019-2024 ($)
Table 36: Biopharmaceutical Market By Product, Revenue & Volume, By Blood Components, 2019-2024 ($)
Table 37: Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2019-2024 ($)
Table 38: Biopharmaceutical Market By Manufacturing Process, Revenue & Volume, By Single-Use System, 2019-2024 ($)
Table 39: Biopharmaceutical Market By Manufacturing Process, Revenue & Volume, By Multi- Use System, 2019-2024 ($)
Table 40: Biopharmaceutical Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 41: Biopharmaceutical Market By Application, Revenue & Volume, By Rheumatology, 2019-2024 ($)
Table 42: Biopharmaceutical Market By Application, Revenue & Volume, By Oncology, 2019-2024 ($)
Table 43: Biopharmaceutical Market By Application, Revenue & Volume, By Cardiology, 2019-2024 ($)
Table 44: Biopharmaceutical Market By Application, Revenue & Volume, By Dermatology, 2019-2024 ($)
Table 45: Biopharmaceutical Market By Application, Revenue & Volume, By Gastroenterology, 2019-2024 ($)
Table 46: Biopharmaceutical Market, Revenue & Volume, By End Use, 2019-2024 ($)
Table 47: Biopharmaceutical Market By End Use, Revenue & Volume, By Biopharmaceutical Companies, 2019-2024 ($)
Table 48: Biopharmaceutical Market By End Use, Revenue & Volume, By Hospitals, 2019-2024 ($)
Table 49: Biopharmaceutical Market By End Use, Revenue & Volume, By Research Institutes, 2019-2024 ($)
Table 50: Biopharmaceutical Market By End Use, Revenue & Volume, By CROs, 2019-2024 ($)
Table 51: Biopharmaceutical Market By End Use, Revenue & Volume, By Diagnostic Labs, 2019-2024 ($)
Table 52: North America Biopharmaceutical Market, Revenue & Volume, By Source, 2019-2024 ($)
Table 53: North America Biopharmaceutical Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 54: North America Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2019-2024 ($)
Table 55: North America Biopharmaceutical Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 56: North America Biopharmaceutical Market, Revenue & Volume, By End Use, 2019-2024 ($)
Table 57: South america Biopharmaceutical Market, Revenue & Volume, By Source, 2019-2024 ($)
Table 58: South america Biopharmaceutical Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 59: South america Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2019-2024 ($)
Table 60: South america Biopharmaceutical Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 61: South america Biopharmaceutical Market, Revenue & Volume, By End Use, 2019-2024 ($)
Table 62: Europe Biopharmaceutical Market, Revenue & Volume, By Source, 2019-2024 ($)
Table 63: Europe Biopharmaceutical Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 64: Europe Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2019-2024 ($)
Table 65: Europe Biopharmaceutical Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 66: Europe Biopharmaceutical Market, Revenue & Volume, By End Use, 2019-2024 ($)
Table 67: APAC Biopharmaceutical Market, Revenue & Volume, By Source, 2019-2024 ($)
Table 68: APAC Biopharmaceutical Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 69: APAC Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2019-2024 ($)
Table 70: APAC Biopharmaceutical Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 71: APAC Biopharmaceutical Market, Revenue & Volume, By End Use, 2019-2024 ($)
Table 72: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By Source, 2019-2024 ($)
Table 73: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 74: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2019-2024 ($)
Table 75: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 76: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By End Use, 2019-2024 ($)
Table 77: Russia Biopharmaceutical Market, Revenue & Volume, By Source, 2019-2024 ($)
Table 78: Russia Biopharmaceutical Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 79: Russia Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2019-2024 ($)
Table 80: Russia Biopharmaceutical Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 81: Russia Biopharmaceutical Market, Revenue & Volume, By End Use, 2019-2024 ($)
Table 82: Israel Biopharmaceutical Market, Revenue & Volume, By Source, 2019-2024 ($)
Table 83: Israel Biopharmaceutical Market, Revenue & Volume, By Product, 2019-2024 ($)
Table 84: Israel Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2019-2024 ($)
Table 85: Israel Biopharmaceutical Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 86: Israel Biopharmaceutical Market, Revenue & Volume, By End Use, 2019-2024 ($)
Table 87: Top Companies 2018 (US$)Biopharmaceutical Market, Revenue & Volume
Table 88: Product Launch 2018-2019Biopharmaceutical Market, Revenue & Volume
Table 89: Mergers & Acquistions 2018-2019Biopharmaceutical Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Biopharmaceutical Market 2019-2024
Figure 2: Market Share Analysis for Biopharmaceutical Market 2018 (US$)
Figure 3: Product Comparison in Biopharmaceutical Market 2018-2019 (US$)
Figure 4: End User Profile for Biopharmaceutical Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Biopharmaceutical Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Biopharmaceutical Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Biopharmaceutical Market 2018-2019
Figure 8: Ecosystem Analysis in Biopharmaceutical Market 2018
Figure 9: Average Selling Price in Biopharmaceutical Market 2019-2024
Figure 10: Top Opportunites in Biopharmaceutical Market 2018-2019
Figure 11: Market Life Cycle Analysis in Biopharmaceutical Market
Figure 12: GlobalBy SourceBiopharmaceutical Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy ProductBiopharmaceutical Market Revenue, 2019-2024 ($)
Figure 14: GlobalBy Manufacturing ProcessBiopharmaceutical Market Revenue, 2019-2024 ($)
Figure 15: GlobalBy ApplicationBiopharmaceutical Market Revenue, 2019-2024 ($)
Figure 16: GlobalBy End UseBiopharmaceutical Market Revenue, 2019-2024 ($)
Figure 17: Global Biopharmaceutical Market - By Geography
Figure 18: Global Biopharmaceutical Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 19: Global Biopharmaceutical Market CAGR, By Geography, 2019-2024 (%)
Figure 20: North America Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 21: US Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 22: US GDP and Population, 2018-2019 ($)
Figure 23: US GDP – Composition of 2018, By Sector of Origin
Figure 24: US Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Canada Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 26: Canada GDP and Population, 2018-2019 ($)
Figure 27: Canada GDP – Composition of 2018, By Sector of Origin
Figure 28: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 29: Mexico Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 30: Mexico GDP and Population, 2018-2019 ($)
Figure 31: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 32: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 33: South America Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 34: Brazil Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 35: Brazil GDP and Population, 2018-2019 ($)
Figure 36: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 37: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Venezuela Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 39: Venezuela GDP and Population, 2018-2019 ($)
Figure 40: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 41: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Argentina Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 43: Argentina GDP and Population, 2018-2019 ($)
Figure 44: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 45: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Ecuador Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 47: Ecuador GDP and Population, 2018-2019 ($)
Figure 48: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 49: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Peru Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 51: Peru GDP and Population, 2018-2019 ($)
Figure 52: Peru GDP – Composition of 2018, By Sector of Origin
Figure 53: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Colombia Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 55: Colombia GDP and Population, 2018-2019 ($)
Figure 56: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 57: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Costa Rica Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 59: Costa Rica GDP and Population, 2018-2019 ($)
Figure 60: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 61: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 62: Europe Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 63: U.K Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 64: U.K GDP and Population, 2018-2019 ($)
Figure 65: U.K GDP – Composition of 2018, By Sector of Origin
Figure 66: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Germany Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 68: Germany GDP and Population, 2018-2019 ($)
Figure 69: Germany GDP – Composition of 2018, By Sector of Origin
Figure 70: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 71: Italy Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 72: Italy GDP and Population, 2018-2019 ($)
Figure 73: Italy GDP – Composition of 2018, By Sector of Origin
Figure 74: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 75: France Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 76: France GDP and Population, 2018-2019 ($)
Figure 77: France GDP – Composition of 2018, By Sector of Origin
Figure 78: France Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Netherlands Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 80: Netherlands GDP and Population, 2018-2019 ($)
Figure 81: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 82: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Belgium Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 84: Belgium GDP and Population, 2018-2019 ($)
Figure 85: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 86: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Spain Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 88: Spain GDP and Population, 2018-2019 ($)
Figure 89: Spain GDP – Composition of 2018, By Sector of Origin
Figure 90: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 91: Denmark Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 92: Denmark GDP and Population, 2018-2019 ($)
Figure 93: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 94: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 95: APAC Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 96: China Biopharmaceutical Market Value & Volume, 2019-2024
Figure 97: China GDP and Population, 2018-2019 ($)
Figure 98: China GDP – Composition of 2018, By Sector of Origin
Figure 99: China Export and Import Value & Volume, 2018-2019 ($)Biopharmaceutical Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 100: Australia Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 101: Australia GDP and Population, 2018-2019 ($)
Figure 102: Australia GDP – Composition of 2018, By Sector of Origin
Figure 103: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 104: South Korea Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 105: South Korea GDP and Population, 2018-2019 ($)
Figure 106: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 107: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 108: India Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 109: India GDP and Population, 2018-2019 ($)
Figure 110: India GDP – Composition of 2018, By Sector of Origin
Figure 111: India Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Taiwan Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 113: Taiwan GDP and Population, 2018-2019 ($)
Figure 114: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 115: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Malaysia Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 117: Malaysia GDP and Population, 2018-2019 ($)
Figure 118: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 119: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Hong Kong Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 121: Hong Kong GDP and Population, 2018-2019 ($)
Figure 122: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 123: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 124: Middle East & Africa Biopharmaceutical Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 125: Russia Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 126: Russia GDP and Population, 2018-2019 ($)
Figure 127: Russia GDP – Composition of 2018, By Sector of Origin
Figure 128: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Israel Biopharmaceutical Market Value & Volume, 2019-2024 ($)
Figure 130: Israel GDP and Population, 2018-2019 ($)
Figure 131: Israel GDP – Composition of 2018, By Sector of Origin
Figure 132: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 133: Entropy Share, By Strategies, 2018-2019* (%)Biopharmaceutical Market
Figure 134: Developments, 2018-2019*Biopharmaceutical Market
Figure 135: Company 1 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 1 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 1 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 2 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 2 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 2 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 3 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 3 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 3 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 4 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 4 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 4 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 5 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 5 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 5 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 6 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 6 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 6 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 7 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 7 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 7 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 8 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 8 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 8 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 9 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 9 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 9 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 10 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 10 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 10 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 11 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 11 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 11 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 12 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 12 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 12 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 13 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 13 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 13 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 14 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 14 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 14 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 177: Company 15 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 178: Company 15 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 179: Company 15 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)